证券代码：600322 证券简称：津投城开 公告编号：2025—073 天津津投城市开发股份有限公司 十一届三十三次临时董事会会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 天津津投城市开发股份有限公司（以下简称"公司"）十一届三十三次临时 董事会会议于 2025 年 8 月 1 日以通讯方式召开。会议通知和会议资料已于 2025 年 7 月 29 日以电子邮件形式向全体董事发出。本次会议应出席董事 10 名，实际 出席会议的董事 10 名。本次会议由代董事长张亮先生主持，公司全体监事及高 级管理人员列席了会议，会议的召集、召开符合《公司法》和《公司章程》等相 关规定。 二、董事会会议审议情况 会议审议并通过如下决议： （一）关于补选公司非独立董事的议案 表决结果：以 10 票同意、0 票反对、0 票弃权获得通过。 鉴于崔巍先生辞去公司董事职务，为完善公司治理结构，保证公司董事会规 范运作，公司董事会提名臧强先生（简历附后）为公司第十一届董事会非独立董 事候选人。候选董事任期自股东大会审议 ...

Group 1 - Liu Pharmaceutical Group plans to repurchase shares worth between 100 million and 200 million yuan, with a maximum repurchase price of 25.70 yuan per share [1] - Dongshan Precision intends to invest up to 1 billion USD to build a high-end printed circuit board project to meet the long-term demand for high-end printed circuit boards in emerging scenarios such as AI [1] - Bomaike reported a net profit of 12.39 million yuan for the first half of the year, a year-on-year decline of 80.42% [2] Group 2 - Western Mining achieved a net profit of 1.869 billion yuan in the first half of the year, a year-on-year increase of 15% [2] - Fuliwang expects a net loss of approximately 17 million yuan for the first half of the year, a decrease of 137.12% compared to the same period last year [2] - Digital Certification anticipates a net loss of between 80 million and 96 million yuan for the first half of the year, compared to a loss of 29.25 million yuan in the same period last year [3] Group 3 - Shanghai Construction reported a net profit of 710 million yuan for the first half of the year, a year-on-year decrease of 14.04% [5] - Funneng Co. achieved a net profit of 1.337 billion yuan in the first half of the year, a year-on-year increase of 12.48% [6] - Tengda Construction's total contract amount for the first half of the year decreased by 17.55% year-on-year [7] Group 4 - Fudan Fuhua decided to terminate the public transfer of a 28% stake in a subsidiary due to the lack of a deposit from potential buyers [9] - Fulei Ant's subsidiary has decided to cease operations due to intense competition in the photovoltaic industry and ongoing losses [11] - Dongfang Ocean's subsidiary received a medical device registration certificate for a folic acid testing kit [14] Group 5 - Huayu Pharmaceutical's subsidiary received overseas listing approvals for several products [16] - Feima International received a performance commitment compensation of 437 million yuan from its controlling shareholder [16] - Guangshen Railway signed a cooperation agreement for the Guangzhou East Station renovation project with a total investment of approximately 16.66 billion yuan [16] Group 6 - Anhui Construction won the bid for the S68 Jingde to Jixi Expressway project with an estimated total investment of 5.7 billion yuan [18] - China Communications Construction Company signed new contracts worth 991.054 billion yuan in the first half of the year, a year-on-year increase of 3.14% [19] - Kehui Co. plans to use up to 70 million yuan of idle funds for cash management [22] Group 7 - Biological Shares' subsidiary received a clinical trial approval for a cat mRNA vaccine, the first of its kind in China [23] - Ruipu Biological received a clinical trial approval for a pig mRNA vaccine, which is the first economic animal mRNA vaccine in China [24] - Nanjing New Hundred's major assets were judicially frozen due to liquidity debt crisis faced by its controlling shareholder [27] Group 8 - Changshu Bank plans to merge three village banks and establish branches, pending shareholder approval [28] - Yong'an Pharmaceutical plans to reduce its holdings by up to 2.6323 million shares [29] - Zhujiang Co. received approval from the Shanghai Stock Exchange for a stock issuance to specific targets [31] Group 9 - Sanyangma's subsidiary signed a 120 million yuan procurement contract for sensor products [33] - Jintou City Development plans to purchase a villa property for approximately 7.1854 million yuan [35] - Yuanli Co. intends to acquire 100% of Tongsheng Co. through a combination of cash and stock issuance [36] Group 10 - Xin'an Century's controlling shareholder plans to reduce holdings by up to 2.22% of the company's shares [36] - Fute Technology plans to raise up to 528 million yuan through a private placement for various projects [36] - Helen Piano's actual controller is set to change, with stock resuming trading [37] Group 11 - Weiergao expects a net profit increase of 12.55% to 30.87% for the first half of the year [38] - Saiwei Microelectronics plans to transfer up to 18% of its shares through an agreement [40] - Yongli Co. intends to acquire a 22.75% stake in a subsidiary [42] Group 12 - ST Xiachuang plans to publicly transfer a 20% stake in Guangdong Yuweiji [43] - Dema Technology's shareholders plan to transfer 778.84 million shares through an inquiry [45] - Zhongshi Technology's shareholders plan to reduce holdings by up to 2.86% of the company's shares [46] Group 13 - Wufang Optoelectronics' controlling shareholder plans to reduce holdings by up to 0.93% of the company's shares [48] - Fusenmei's chairman has been detained, temporarily unable to fulfill his duties [49] - Reliable Co.'s shareholders plan to reduce holdings by a total of up to 2.63% of the company's shares [51] Group 14 - Gao Neng Environment plans to repurchase shares worth between 100 million and 150 million yuan [53]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 天津津投城市开发股份有限公司（以下简称"公司"）董事会于近日收到公 司董事崔巍先生的书面《辞职报告》。崔巍先生因工作调整原因，向公司董事会 提出辞去公司董事职务，辞职后本人不再担任公司任何职务。根据相关规定，崔 巍先生的辞职自辞职报告送达董事会之日起生效。 证券代码：600322 证券简称：津投城开 公告编号：2025-072 天津津投城市开发股份有限公司 关于公司董事辞职的公告 崔巍先生在担任公司董事期间，恪尽职守、勤勉尽责，董事会及公司对其任 职期间为公司发展做出的贡献表示衷心感谢！ 特此公告。 天津津投城市开发股份有限公司 董 事 会 2025 年 7 月 26 日 | 姓名 | 离任职务 | 离任时间 | 原定任期 | 离任原因 | 是否继续在上市公司 | 是否存在未履行 | | --- | --- | --- | --- | --- | --- | --- | | | | | 到期日 | | 及其控股子公司任职 | 完毕的公开承诺 | | 崔巍 | 董事 | 2025- ...

证券代码：600322 证券简称：津投城开 公告编号：2025一069 登录新浪财经APP 搜索【信披】查看更多考评等级 关联董事雷雨先生、赵宝军先生回避表决。 该议案已经公司十一届董事会第九次独立董事专门会议审议通过，同意提交董事会审议；本议案无需提 交公司股东大会审议。 天津津投城市开发股份有限公司 十一届三十二次临时董事会会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 天津津投城市开发股份有限公司（以下简称"公司"）十一届三十二次临时董事会会议于2025年7月24日 以通讯方式召开。会议通知和会议资料已于2025年7月18日以电子邮件形式向全体董事发出。本次会议 应出席董事11名，实际出席会议的董事11名。本次会议由代董事长张亮先生主持，公司全体监事及高级 管理人员列席了会议，会议的召集、召开符合《公司法》和《公司章程》等相关规定。 二、董事会会议审议情况 会议审议并通过如下决议： （一）关于购买资产暨关联交易的议案 表决结果：以9票同意、0票反对、0票弃权获得通过。 具体内容详见公 ...

一、董事会会议召开情况 证券代码：600322 证券简称：津投城开 公告编号：2025—069 天津津投城市开发股份有限公司 十一届三十二次临时董事会会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 关联董事雷雨先生、赵宝军先生回避表决。 该议案已经公司十一届董事会第九次独立董事专门会议审议通过，同意提交 董事会审议；本议案无需提交公司股东大会审议。 具体内容详见公司另行披露的《天津津投城市开发股份有限公司关于购买资 产暨关联交易的公告》。 特此公告。 天津津投城市开发股份有限公司 董 事 会 天津津投城市开发股份有限公司（以下简称"公司"）十一届三十二次临时 董事会会议于 2025 年 7 月 24 日以通讯方式召开。会议通知和会议资料已于 2025 年 7 月 18 日以电子邮件形式向全体董事发出。本次会议应出席董事 11 名，实际 出席会议的董事 11 名。本次会议由代董事长张亮先生主持，公司全体监事及高 级管理人员列席了会议，会议的召集、召开符合《公司法》和《公司章程》等相 关规定。 二、董事会会议审议情况 ...

证券代码：600322 证券简称：津投城开 公告编号：2025—071 天津津投城市开发股份有限公司 关于重大资产重组的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、本次交易的进展情况 经公司向上海证券交易所申请，公司股票（股票简称：津投城开，股票代码： 600322）于 2024 年 12 月 18 日开市起停牌，具体内容详见公司分别于 2024 年 12 月 18 日披露的《关于筹划重大资产重组的停牌公告》（公告编号：2024-093） 和 2024 年 12 月 25 日披露的《关于筹划重大资产重组的停牌进展公告》（公告编 号：2024-096）。 2024 年 12 月 31 日，公司召开十一届二十四次临时董事会会议、十一届十一 次临时监事会会议，审议通过了《关于<天津津投城市开发股份有限公司重大资 产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易预案>及其摘 要的议案》等与本次交易相关的议案，具体内容详见公司披露的《天津津投城市 开发股份有限公司重大资产置换、发行股份及支付现金购买资产并募集 ...

证券代码：600322 证券简称：津投城开 公告编号：2025-070 天津津投城市开发股份有限公司 关于购买资产暨关联交易的公告 （一）本次交易的基本情况 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 交易简要内容：天津津投城市开发股份有限公司（以下简称"公司"）拟 通过参与天津产权交易中心有限公司（以下简称"天津产权交易中心"）公开挂 牌竞价方式购买天津市天科数创科技股份有限公司（以下简称"天科数创"）名下 碧岭园 C15 别墅房产，预计交易金额为 718.54 万元。 本次交易构成关联交易 本次交易不构成重大资产重组 本次交易事项已经公司十一届三十二次临时董事会会议审议通过，关联 董事回避表决。在董事会审议前，公司独立董事专门会议对本次关联交易事项审 议通过。该交易无需提交公司股东大会审议。 过去 12 个月，公司与控股股东天津国有资本投资运营有限公司（以下简 称"津投资本"）发生的关联交易共 3 笔，累计交易金额为 150,309.91 万元，占 公司最近一期经审计净资产的 8886.87% ...

津投城开（600322）公告，公司计划通过天津产权交易中心公开挂牌竞价方式购买天科数创名下碧岭园 C15别墅房产，预计交易金额为718.54万元。此举旨在提高资产经营水平，完善资产经营管理业务。本 次交易构成关联交易，不构成重大资产重组，已获董事会审议通过，关联董事回避表决。本次交易尚需 履行天津产权交易中心的相应程序，能否成功存在不确定性。过去12个月，公司与控股股东津投资本发 生的关联交易共3笔，累计交易金额为15.03亿元，占公司最近一期经审计净资产的8886.87%(不含本次 交易)。 ...

[Key Highlights of Performance Forecast](index=1&type=section&id=Important%20Content%20Reminder) The company anticipates continued losses for the first half of 2025, with significant projected net losses attributable to shareholders 2025 Semi-Annual Performance Forecast | Indicator | Projected Amount (Yuan) | | :--- | :--- | | Net Profit Attributable to Shareholders | -500 million to -600 million Yuan | | Net Profit After Non-Recurring Items | -485 million to -585 million Yuan | [Details of Current Period Performance Forecast](index=1&type=section&id=I.%20Current%20Period%20Performance%20Forecast%20Situation) This unaudited performance forecast for H1 2025 projects significant net losses based on preliminary financial department estimates - The performance forecast period is from January 1, 2025, to June 30, 2025[3](index=3&type=chunk) - The data in this performance forecast has not been audited by a certified public accountant[3](index=3&type=chunk) [Review of Prior Period Performance](index=1&type=section&id=II.%20Operating%20Performance%20and%20Financial%20Status%20in%20the%20Prior%20Period) The company experienced losses in the prior year's comparable period, with the current period's projected losses significantly exceeding those of the previous year Prior Period (2024 Semi-Annual) Financial Data | Indicator | Amount (Yuan) | | :--- | :--- | | Total Profit | -205 million Yuan | | Net Profit Attributable to Shareholders | -202 million Yuan | | Net Profit After Non-Recurring Items | -269 million Yuan | | Earnings Per Share | -0.1829 Yuan | [Analysis of Reasons for Current Period Pre-Loss](index=1&type=section&id=III.%20Main%20Reasons%20for%20Current%20Period%20Pre-Loss) Continued losses are primarily attributed to substantial financial expenses from high financing and insufficient operating revenue to cover costs and expenses - Despite optimizing its interest-bearing debt structure, the company incurred significant financial expenses due to its high financing scale[5](index=5&type=chunk)[6](index=6&type=chunk) - Insufficient operating revenue recognized during the reporting period to cover costs and various period expenses is a direct cause of the loss[6](index=6&type=chunk) [Risk Disclosure and Other Explanations](index=2&type=section&id=IV.%20Risk%20Disclosure) The company cautions that this unaudited performance forecast is preliminary and subject to adjustment, advising investors to refer to the official semi-annual report and be aware of investment risks - This performance forecast is a preliminary estimate by the company's finance department, unaudited by a certified public accountant, and final data may be subject to adjustment[7](index=7&type=chunk) - The final accurate financial data will be based on the company's officially disclosed 2025 semi-annual report, reminding investors to be aware of investment risks[8](index=8&type=chunk)

津投城开（600322）公告，经财务部门初步测算，预计2025年半年度实现归属于上市公司股东的净利润 为-5亿元至-6亿元之间，与上年同期相比将继续亏损。扣除非经常性损益事项后，预计2025年半年度实 现归属于上市公司股东的净利润为-4.85亿元至-5.85亿元之间。报告期内，公司虽进行了有息负债结构 优化，但因融资规模较高，报告期财务费用较大。同时，确认的营业收入不足以覆盖成本及各项期间费 用，导致本期业绩继续亏损。 ...